Guided Bone Regeneration Market: Understanding Size and Growth Factors for Strategic Planning

Guided Bone Regeneration Market Outlook
In 2023, the global guided bone regeneration market reached a revenue of US$ 755.6 million. The market is projected to grow at a CAGR of 4.6%, reaching a valuation of US$ 1.2 billion by 2033. According to Persistence Market Research, bone graft substitutes accounted for a market value of US$ 514 million in 2023.
Between 2017 and 2022, the guided bone regeneration market recorded a CAGR of 3.1%, accounting for a 14.3% share of the global bone regeneration market in 2022.
The increasing prevalence of oral diseases has driven the demand for bone graft substitutes in dentistry. The WHO Global Oral Health Status Report indicated that around 3.5 billion people worldwide were affected by oral diseases in 2022, mainly due to poor hygiene and diet. Guided bone regeneration, a technique used for hard tissue reconstruction in dentistry, is anticipated to grow as the prevalence of oral diseases rises, positively impacting the market. Furthermore, technological advancements have propelled the market forward. Synthetic bone substitutes have progressively replaced natural bone grafts due to continuous technological innovations. The development of hybrid grafts, which incorporate osteogenic cells to stimulate bone regeneration and growth factors, is poised to shape the future of dental bone grafting and dental implants.